Matthew Gillmor

You had mentioned that 3 divisions represented 50% of the impact Can you give some context

give us an update in terms of how things are playing out and if there's any signs that those markets are improving

Can you give us a sense for how the exchange reforms and the subsidy expirations will impact the volume outlook?

There was a little bit of an improvement this quarter versus last quarter. Sam just mentioned some of the seasonal dynamics. Can you give us a sense for some of the service lines

there was a comment about a handful of markets that were underperforming. Can you give us some sense for the drivers of that underperformance

do you see how system competitors behaving any differently in terms of their CapEx priorities or investments? Maybe that creates an opportunity for HCA

I want to see if there's any commentary on the California wildfires. And I know you've got a couple of facilities in the L.A. area, but any impact there to call out

Can you just remind us the proportion of MA members that are capitated?

If this program is renewed for fiscal 26, would the sizing of the 2026 program be about the same

how we should think about the ramp of facility in San Antonio once it gets the CMS certification back

it seemed like rate outperformed even excluding the DPP. What drove the stronger price in the quarter, and why do you expect moderation for the rest of the year?

on professional fees, any trend updates and what are you doing to alleviate pressure, particularly in radiology?

For the programs that are not yet approved like Florida and I think maybe California, do you have any sense for where those approval processes stand with CMS?

Is there a way for us to think about how that breaks down the net benefit between acute and behavioral?

is there any geographic variation to call out to highlight, particularly in some of your larger markets like Las Vegas?

I wanted to see if there was anything to report with respect to professional fees and physician expenses

Are you able to quantify what that impact would be? Or just give us some sense for the drag on the same-store?

are you still expecting $997 million from the last disclosure? Or is that number changed at all?

Any areas of particular outperformance to call out and sort of how you're feeling about the sustainability of that?

Can you get some detail on nature of those settlements? Are those mostly tied to value-based care contracts and Optum Health?